Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

34.90p
   
  • Change Today:
    -0.100p
  • 52 Week High: 71.80
  • 52 Week Low: 34.20
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 3,721,382
  • Market Cap: £188.60m
  • RiskGrade: 119

Regulatory News

Further update on timing of preliminary results 22-Apr-2024 07:00 RNS
Update on Timing of Preliminary Results 05-Apr-2024 07:00 RNS
Total Voting Rights 02-Apr-2024 11:12 RNS
Total Voting Rights 04-Mar-2024 08:00 RNS
Notification of Full Year Results 04-Mar-2024 07:00 RNS
New Chair Appointment 05-Feb-2024 07:00 RNS
Full Year Trading Update 29-Jan-2024 07:00 RNS
Block Listing Six Monthly Return 02-Jan-2024 10:51 RNS
Total Voting Rights 01-Dec-2023 12:23 RNS
Notification of Major Holdings 09-Nov-2023 11:17 RNS
Appointment of Non-Executive Directors 07-Nov-2023 07:00 RNS
Total Voting Rights 01-Nov-2023 12:50 RNS
Director Dealings 16-Oct-2023 18:13 RNS
Notification of Major Interest in Shares 12-Oct-2023 14:51 RNS
Grant of Options to Directors 05-Oct-2023 16:39 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 34.90p
Change Today -0.100p
% Change -0.29 %
52 Week High 71.80
52 Week Low 34.20
Volume 3,721,382
Shares Issued 540.40m
Market Cap £188.60m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.31% above the market average84.31% above the market average84.31% above the market average84.31% above the market average84.31% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
68.22% below the market average68.22% below the market average68.22% below the market average68.22% below the market average68.22% below the market average
1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average1.75% above the sector average
Income
9.89% above the market average9.89% above the market average9.89% above the market average9.89% above the market average9.89% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
88.8% below the market average88.8% below the market average88.8% below the market average88.8% below the market average88.8% below the market average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 25-Apr-2024

Time Volume / Share Price
16:35 34,082 @ 34.90p
16:35 111 @ 34.90p
16:35 1,254 @ 34.90p
16:35 1,641 @ 34.90p
16:35 2,071 @ 34.90p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page